A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be protective against developing dementia. While there is currently no ...

Health and Human Services Secretary Robert F. Kennedy Jr. this week made his strongest endorsement yet of the measles vaccine amid an ongoing outbreak that has killed three and infected more than ...

(WNDU) - Measles cases continue to spread nationwide, and as the disease gets closer to Michiana, we’re learning that a specific group of people may have received an ineffective vaccine.

The flu vaccine is recommended annually for all Americans 6 months and older, per the Centers for Disease Control and Prevention — but a new study from Cleveland Clinic suggests that it might ...

"We encourage people to get the measles vaccine," Kennedy told CBS News chief medical correspondent Dr. Jon LaPook on Tuesday during his Make America Healthy Again tour in Arizona, marking the ...

Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine skeptic, said in an interview Tuesday that he encourages people to get vaccinated against measles after an outbreak has killed ...

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters. Robert F. Kennedy, Jr. is trying to have it both ways when it comes to the measles vaccine.

Cancer vaccines have been a tantalizing idea for decades, but the vast complexity of the human immune system has posed significant challenges. Now, technological advances like rapid DNA sequencing ...

A new large-scale study conducted by the Cleveland Clinic on the effectiveness of the 2024–2025 influenza vaccine shows that those who took the shot had a 27 percent higher risk of infection compared ...

Kate Nalepinski is a Newsweek journalist based in New York City. Kate joined Newsweek in May 2024. She is a graduate of Ithaca College. Secretary of Health and Human Services Robert F. Kennedy Jr ...

Just last week, the US Food and Drug Administration delayed a decision on full approval of Novavax’s Covid-19 vaccine even though it was on track to be cleared, leaving many public health ...